Replicating true in vivo biology. Whether you are innovating in drug discovery, cosmetology, preventive medicine, or alternative proteins, our patented physioscaffolds accelerate your research, cut costs, and deliver reliable data.
Replicate human biology with unprecedented accuracy. Our patented Physioscaffolds provide the ultimate 3D microenvironment for your cells. Whether you are modelling skin tissue, liver function, or muscle fibers, you get highly predictive data you can trust.
Accelerated Time-to-Market
Streamline your workflows and speed up your discovery phase. By delivering reliable physiological responses earlier in the process, Organisyl® shortens your R&D cycles, helping you bring innovative cosmetics or life-saving vaccines to market faster than ever.
Drastic Cost Reduction
Eliminate the financial drain of late-stage clinical failures. Our platform minimizes wasted reagents, avoids useless testing, and ensures you only invest in viable candidates. Fail fast, or succeed with absolute certainty.
What is Organisyl®?
Organisyl® is a breakthrough technology that faithfully reproduces the extracellular matrix (ECM) specific to each human organ or tissue, whether healthy or pathological.
By combining hyaluronic acid with adhesion proteins, collagens, and other natural agents found in the extracellular matrix, Organisyl® recreates an in vitro cellular environment with unparalleled precision, ensuring the reproducibility, productivity, and quality of cells, tissues, or organs recreated through bioengineering.
Our technology adapts to your specific cell lines and research goals across diverse industries.
Bridging the translational gap with predictive human biology
The pharmaceutical industry faces a 90% clinical failure rate, costing $2B per successful drug, primarily due to non-predictive animal testing and basic 2D cell cultures that fail to accurately predict human responses, leading to costly late-stage clinical trial failures.
Organisyl®’s patented Physioscaffolds recreate the complex human extracellular matrix (ECM) in vitro, providing a physiologically relevant microenvironment that standard methods lack.
By using organoids in our biomimetic 3D platforms, researchers gain access to high-fidelity data regarding drug efficacy, safety, and ADME much earlier in the drug discovery pipeline. This enables you to “fail fast and cheap” with unsuitable candidates and confidently accelerate promising compounds, significantly de-risking your development process and shortening time-to-market.
And to go further, amplifying and differentiating stem cells such as iPSCs is highly improved in Organisyl® Physioscaffolds, allowing us to go to the future of medicine that is regenerative medicine.
Pioneering Precision Health with Patient-Specific Models
The future of medicine moves beyond “one-size-fits-all” approaches toward tailored treatments.
Organisyl empowers this shift by enabling the robust culture of patient-derived primary cells or iPSCs (induced pluripotent stem cells) under physiological conditions that maintain their original phenotype.
Our platform allows researchers and clinicians to create ex vivo biological “avatars” of a patient’s specific pathology—such as a tumor biopsy. This enables pre-screening of therapeutic strategies to identify the most effective treatment for that individual prior to administration. By predicting individual patient responses in the lab, we help pioneer new frontiers in personalized therapy and functional precision medicine.
Ethical innovation through realistic 3D skin modeling
Facing increasing regulatory bans on animal testing and consumer demand for ethical products, the cosmetics industry needs reliable, cruelty-free testing alternatives.
Organisyl provides the solution with advanced 3D tissue models that mimic human skin with unprecedented realism.
Our technology allows for the reconstruction of full-thickness skin models, including complex dermal-epidermal interactions, which are crucial for testing active ingredients. Whether evaluating anti-aging compounds, hydration levels, or UV protection, our platforms deliver robust, reproducible data to substantiate claims and ensure product safety without relying on animal models. Accelerate your formulation process with confidence in your product’s performance on actual human biology.
Unlocking Scalable Production for Cellular Ingredients: Proteins & Lipids
The future of cellular agriculture extends beyond structured meat cuts; it encompasses the efficient production of essential food ingredients, including bulk protein biomass and high-value cultivated fats.
Organisyl addresses the critical bottleneck of industrial scalability for these diverse applications.
Our edible, biomimetic scaffolds are engineered to support high-density cell culture within large-scale bioreactors. Beyond muscle alignment, our technology provides the crucial microenvironment needed for the robust differentiation of adipocytes (fat cells), enabling the creation of realistic animal-free lipids essential for flavor and mouthfeel. Whether your goal is producing unstructured protein isolates or highly structured adipose tissue, Organisyl is the foundational platform for next-generation sustainable food ingredients.
At Organisyl®, our expertise goes beyond mastering the extracellular matrix and 3D cell culture; it lies in our ability to truly understand your challenges. Our scientific team is dedicated to listening to you and analyzing your specific hurdles.
We don’t offer standardized, off-the-shelf solutions. Instead, we leverage our specialized expertise to co-develop the technological answer that breaks through your scientific bottlenecks and accelerates your R&D.
